Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. on June 25, 2019. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The document announces the scheduling of the Company's Annual General Meeting of Shareholders to be held on July 30, 2019, in Bnei Brak, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meeting logistics and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The primary update is the confirmation of the date, time, and location for the upcoming Annual General Meeting.
Guidance, Outlook, and Management Commentary
The filing includes no management commentary, financial guidance, or outlook. It focuses solely on the administrative details of the shareholder meeting, including the attached Notice and Proxy Statement, Proxy Card for ordinary share holders, and Voting Instruction Card for ADS holders.
Key Facts for Investor Verification
- Meeting Date: July 30, 2019.
- Meeting Time: 11:00 a.m. Israel time.
- Meeting Location: Offices of Doron, Tikotzky, Kantor, Gutman, Nass & Amit Gross, B.S.R 4 Tower, 33rd Floor, 7 Metsada Street, Bnei Brak, Israel.
- Voting Materials: Shareholders should review Exhibit 99.1 (Notice and Proxy Statement), Exhibit 99.2 (Proxy Card), and Exhibit 99.3 (Voting Instruction Card) for voting procedures.
- Financial Data: Investors must refer to the Company's Form 20-F or other financial reports for actual financial metrics, as none are included in this filing.